Inventor · disambiguated record
Anita Kavlie
Also filed as: KAVLIE ANITA
20 granted patents·13 pending applications·281 citations·filing 2008–2023
95Inventor score
Top patents by PatentIndex Score
33 records- 0197US8268314B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2009·Granted Sep 18, 2012·70 cites·18 claims
- 0296US9475885B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2015·Granted Oct 25, 2016·15 cites·31 claims
- 0395US8133979B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2009·Granted Mar 13, 2012·19 cites·10 claims
- 0494US8945552B2Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2011·Granted Feb 3, 2015·36 cites·12 claims
- 0594US8703130B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2012·Granted Apr 22, 2014·23 cites·12 claims
- 0693US8034905B2Anti-VEGF antibody compositions and methodsAFFITECH RES AS·Filed 2008·Granted Oct 11, 2011·41 cites·19 claims
- 0792US9708396B2Bispecific anti-VEGF/anti-ANG-2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jul 18, 2017·16 cites·17 claims
- 0892US8361747B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted Jan 29, 2013·10 cites·4 claims
- 0991US9011860B2Compositions for inhibiting MASP-2 dependent complement activationDUDLER THOMAS·Filed 2012·Granted Apr 21, 2015·20 cites·24 claims
- 1091US8399626B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Mar 19, 2013·9 cites·5 claims
- 1187US2023227543A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1284US9421256B2Anti-VEGF antibody compositions and methodsAFFITECH RES AS·Filed 2013·Granted Aug 23, 2016·8 cites·45 claims
- 1384US9340609B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted May 17, 2016·3 cites·5 claims
- 1484US2023399391A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1583US2024092938A1Compositions for inhibiting masp-2 dependent complement activationOMEROS CORP·Filed 2023·Application pending·0 cites
- 1682US8394943B2Anti-VEGF antibody compositions and methodsKAVLIE ANITA·Filed 2011·Granted Mar 12, 2013·8 cites·8 claims
- 1781US9109027B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Aug 18, 2015·2 cites·2 claims
- 1880US2020262904A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1978US2021388071A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2073US11613589B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2020·Granted Mar 28, 2023·0 cites·13 claims
- 2172US2021047394A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2270US10683367B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2018·Granted Jun 16, 2020·0 cites·33 claims
- 2369US2018282404A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2467US8748107B2Isolated antibodies which bind to CXC chemokine receptor 4KAVLIE ANITA·Filed 2011·Granted Jun 10, 2014·1 cites·36 claims
- 2566US9073986B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2013·Granted Jul 7, 2015·0 cites·6 claims
- 2664US10047165B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2016·Granted Aug 14, 2018·0 cites·9 claims
- 2764US2017029493A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2861US2017369566A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2961US2015284457A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 3059US2015191535A1Bispecific, bivalent anti-vegf/anti-ang2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3158US9353185B2AntibodiesAFFITECH RES AS·Filed 2014·Granted May 31, 2016·0 cites·37 claims
- 3251US2017240626A1Bispecific, bivalent anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3349US2016244527A1AntibodiesAFFITECH RES AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anita Kavlie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →